Schedule 13G ownership disclosure

ETERNA THERAPEUTICS INC

Common stock, par value $0.005 per share · CUSIP: 114082209

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nicholas Jason Singer

    Shares: 2,565,001.00 · Class: 4.92%

  • Purchase Capital LLC

    Shares: 1,000,001.00 · Class: 1.95%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-014538
Form type
SCHEDULE 13G/A
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub